doi: 10.1001/archopht.1987.01060030096034.PMID: 3827714
About This Article Thanks to all authors for creating a page that has been read 65,742 times
The GLP-1 and GIP receptors work together to improve insulin production, reduce appetite, and promote weight loss
The core threat is disintermediation, where patients get a one-time prescription from their primary care doctor and then access GLP-1s directly through TrumpRx rather than paying $145/month for Ro's subscription that bundles telehealth, labs, titration, and coaching, forcing Ro to immediately cut Wegovy prices to $349/month to match TrumpRx's floor and raising the strategic question of whether Ro's care management can justify a subscription when patients can route around it
For example, combining tirzepatide with other GLP-1 receptor agonists is generally not recommended, as they have similar mechanisms of action and could lead to overlapping side effects